(Q37171284)

18 August 2017

1 reference

title

Neurochemistry and child psychiatry (English)

1 reference

18 August 2017

Neurochemistry and Child Psychiatry (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

0 references

0 references

D. J. Cohen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A18499

17 October 2022

J. G. Young

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A18499

17 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18499

17 October 2022

publication date

1 January 1977

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:S000271380961596X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

https://api.elsevier.com/content/article/PII:S000271380961596X?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Journal of the American Academy of Child Psychiatry

17 October 2022

published in

1 reference

18 August 2017

volume

16

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

353-411

1 reference

The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine

18 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

LSD and CNS transmission

2

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Norepinephrine-dopamine interactions and behavior

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Noradrenaline: fate and control of its biosynthesis

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The pineal gland: a neurochemical transducer

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Changes in Enzymes involved in the Biosynthesis and Metabolism of Noradrenaline and Adrenaline after Psychosocial Stimulation

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine histofluorescence: restoration in mammalian brain tissues prepared several hours post mortem

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The use of neurotoxic dihydroxytryptamines as tools for morphological studies and localized lesioning of central indolamine neurons

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Postmortem Changes in Brain Catecholamine Enzymes

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Studies on the uptake of 5-hydroxytryptamine by blood platelets

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism.

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Laboratory predictions of infantile autism based on 5-hydroxytryptamine efflux from blood platelets and their correlation with the rimland E-2 score

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

17 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Hyperphagia and Obesity Following Serotonin Depletion by Intraventricular p -Chlorophenylalanine

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Peptide transmitters: a unifying hypothesis for euphoria, respiration, sleep, and the action of lithium

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Paradoxical Effects of Amphetamine on Preweanling and Postweanling Rats

17 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Platelet monoamine oxidase activity in acute schizophrenia

17 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Participation of central noradrenergic neurons in arterial baroreceptor reflexes in the rabbit

17 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid

17 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Serotonin and central nervous system function

17 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs

17 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid

17 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

preadolescence

47

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Pica and elevated blood lead level in autistic and atypical children

17 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Creatine Phosphokinase Levels in Children With Severe Developmental Disturbances

17 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid

17 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Platelet monoamine oxidase in early childhood autism

17 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Brain Acetylcholine: Control by Dietary Choline

17 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Serotonin and central nervous system syndromes of childhood: A review

17 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Human blood platelet monoamine oxidase

17 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease

17 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Reduced Plasma Norepinephrine Response to Standing in Autonomic Dysfunction

17 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biochemical correlates of affective disorders in children

17 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The nature of receptors regulating the formation of cyclic AMP in brain tissue

17 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Does asymptomatic lead exposure in children have latent sequelae?

17 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat.

17 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Brain Monoamine Oxidase in Mice after Exposure to Aggression and Defeat

17 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Accumulation of 3-methoxy-4-hydroxyphenylglycol-sulfate in rabbit cerebrospinal fluid following probenecid

17 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Altered peripheral nerve conduction velocity. Chronic lead intoxication in children

17 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Modification of brain serotonin by the diet

17 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

17 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

tryptophan hydroxylase

82

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Children at Risk: The Search for the Antecedents of Schizophrenia. Part I. Conceptual Models and Research Methods

17 October 2022

84

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

A schizophreniform behavioral psychosis mediated by dopamine

17 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Pulmonary disposition of circulating vasoactive hormones

17 October 2022

87

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Monamines as mediators of avoidance-escape behavior

17 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Opioid peptides endorphins in pituitary and brain

17 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

An assay for dopamine-β-hydroxylase activity in tissues and serum

17 October 2022

90

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Metabolic products of adrenaline and noradrenaline in human urine

17 October 2022

91

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine

17 October 2022

93

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters†

17 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Self-inhibition by Dopaminergic Neurons

17 October 2022

96

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Endorphins, Brain Peptides That Act like Opiates

17 October 2022

97

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

A sensitive radioenzymatic assay for norepinephrine in tissues and plasma

17 October 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia

17 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The oestrous cycle and monoamine oxidase activity

17 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders

17 October 2022

111

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Neurohumoral interactions and basal ganglia function and dysfunction

17 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Identification of two related pentapeptides from the brain with potent opiate agonist activity

17 October 2022

113

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Role of transmitter uptake mechanisms in synaptic neurotransmission

17 October 2022

115

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine Receptors in the Brain

17 October 2022

116

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The C-Fragment of β-Lipotropin: An Endogenous Neuroleptic or Antipsychotogen?

17 October 2022

120

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

17 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biogenic amines and the states of sleep

17 October 2022

122

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders

17 October 2022

125

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

False adrenergic transmitters

17 October 2022

128

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Amine metabolism in the human brain: Further evaluation of the probenecid test

17 October 2022

130

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat.

17 October 2022

132

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Scope and limitation in dopamine β-hydroxylase measurement

17 October 2022

134

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects

17 October 2022

135

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man

17 October 2022

136

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Influence of pituitary, thyroid, and adrenal hormones on norepinephrine turnover and metabolism in the rat heart.

17 October 2022

137

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression

17 October 2022

142

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

A review of psychoendocrine research on the pituitary-thyroid system

17 October 2022

146

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Decreased ATPase and increased sodiun content of platelets in Down's syndrome. Relation to decreased serotonin content.

17 October 2022

148

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Cholinergic systems in extrapyramidal function

17 October 2022

149

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Central core fibers in an acutely psychotic patient. Evidence for a neurogenic basis for the muscle abnormalities in the acute psychoses

17 October 2022

150

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Multiple tic syndrome (Giles de la Tourette's syndrome)

17 October 2022

155

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biochemistry of catecholamines

17 October 2022

156

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Catecholamines and neurologic diseases (first of two parts).

17 October 2022

157

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites

17 October 2022

158

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.

17 October 2022

160

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Vascular and Brain Dopamine β-Hydroxylase Activity in Young Spontaneously Hypertensive Rats

17 October 2022

161

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Lead-induced inhibition of brain adenyl cyclase

17 October 2022

162

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The influence of monoamine oxidase inhibition on catecholamine synthesis

17 October 2022

164

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Genetic Control of Platelet and Plasma Monoamine Oxidase Activity

17 October 2022

165

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Post-mortem fluorescence histochemistry of monoamine neuron systems in the human brain: a new approach in the search for a neuropathology of schizophrenia

17 October 2022

167

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Effects of inescapable shock upon subsequent escape and avoidance responding

17 October 2022

168

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

A simplified radiometric assay for plasma norepinephrine and epinephrine

17 October 2022

169

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

Cyclic AMP

170

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

(D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic

17 October 2022

171

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets

17 October 2022

172

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

New aspects on the storage of 5-hydroxytryptamine in blood platelets

17 October 2022

175

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone

17 October 2022

176

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Effects of amino acid feedings in schizophrenic patients treated with iproniazid

17 October 2022

178

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

17 October 2022

179

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Thyroid-imipramine clinical and chemical interaction: Evidence for a receptor deficit in depression

17 October 2022

181

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Significance of Plasma Dopamine β-Hydroxylase Activity as an Index of Sympathetic Neuronal Function

17 October 2022

184

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Changes in Adrenal Enzymes synthesizing Catecholamines in Attack Behaviour evoked by Hypothalamic Stimulation in the Cat

17 October 2022

185

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Platelet uptake and efflux of serotonin in subtypes of psychotic children

17 October 2022

187

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Increased Blood Serotonin and Platelets in Early Infantile Autism

17 October 2022

189

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Monoamine Metabolism in Human Brain

17 October 2022

190

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances

17 October 2022

192

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Some structural requirements for inhibition of type A and B forms of rabbit monoamine oxidase by tricyclic psychoactive drugs

17 October 2022

193

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Platelet monoamine oxidase activity in children and adolescents

17 October 2022

194

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The Influence of Organic and Emotional Factors on the Origins, Nature and Outcome of Childhood Psychosis

17 October 2022

197

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Hyperphagia and Increased Growth in Rats After Intraventricular Injection of 5,7-Dihydroxytryptamine

17 October 2022

202

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The serotonergic system in the brain and its possible functional connections with other aminergic systems

17 October 2022

203

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Monoamine Oxidases: the Present Status

17 October 2022

204

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Pathophysiology of the hyperactive child syndrome

17 October 2022

208

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Hyperactivity and brain catecholamines in lead-exposed developing rats

17 October 2022

209

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.

17 October 2022

210

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite

17 October 2022

211

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension

17 October 2022

212

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Biogenic Amines and Emotion

17 October 2022

214

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

17 October 2022

216

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Treatment of Tourette's syndrome with haloperidol, review of 34 cases

17 October 2022

217

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The catabolism of catecholamines. Recent studies

17 October 2022

218

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy

17 October 2022

221

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report

17 October 2022

222

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction

17 October 2022

223

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine

17 October 2022

224

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Stimulation of midbrain raphé neurons: behavioral effects of serotonin release

17 October 2022

225

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

Serotonin

226

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Lead pica produced in rats

17 October 2022

228

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Opiate Receptors in the Brain

17 October 2022

229

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Drugs, neurotransmitters, and schizophrenia

17 October 2022

230

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Neurotransmitter Receptors in the Brain: Biochemical Identification

17 October 2022

231

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs

17 October 2022

232

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders

17 October 2022

233

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Psychotherapeutic Control of Hypertension

17 October 2022

235

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Studies on the mechanism of hormone action

17 October 2022

236

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopaminergic Terminals in the Rat Cortex

17 October 2022

237

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The Pharmacology of 6-Hydroxydopamine

17 October 2022

238

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Choline Administration: Activation of Tyrosine Hydroxylase in Dopaminergic Neurons of Rat Brain

17 October 2022

242

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Stereotaxic mapping of the monoamine pathways in the rat brain

17 October 2022

243

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man

17 October 2022

244

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders

17 October 2022

245

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

17 October 2022

246

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome

17 October 2022

247

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The release and fate of vaso-active hormones in the circulation

17 October 2022

248

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs

17 October 2022

249

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Regulation of norepinephrine biosynthesis

17 October 2022

250

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Serum Dopamine-Beta-Hydroxylase Activity

17 October 2022

253

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Proportional Release of Norepinephrine and Dopamine-β-Hydroxylase from Sympathetic Nerves

17 October 2022

254

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Assay of cathecholamines in human plasma: studies of a single isotope radioenzymatic procedure

17 October 2022

255

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Enhancement of human performance by caffeine and the amphetamines

17 October 2022

256

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Effects of Acute Exposure to Stressors on Subsequent Avoidance-Escape Behavior*

17 October 2022

257

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Effects of Chronic Exposure to Stressors on Avoidance-Escape Behavior and on Brain Norepinephrine*

17 October 2022

258

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia

17 October 2022

261

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

17 October 2022

262

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Control of brain neurotransmitter synthesis by precursor availability and nutritional state

17 October 2022

263

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Brain catechol synthesis: control by train tyrosine concentration

17 October 2022

264

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia

17 October 2022

265

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The Dimethyltryptamine-Forming Enzyme in Blood Platelets: A Study in Monozygotic Twins Discordant for Schizophrenia

17 October 2022

266

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Dopamine β-Hydroxylase Activity in Brains of Chronic Schizophrenic Patients

17 October 2022

267

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Examination of circadian rhythmicity of blood serotonin and platelets in autistic and non-autistic children

17 October 2022

270

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Uptake and efflux of serotonin from platelets of autistic and nonautistic children

17 October 2022

271

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Minimal Brain Dysfunction, Stimulant Drugs, and Autonomic Nervous System Activity

17 October 2022

272

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The role of amine oxidases in the destruction of catecholamines

17 October 2022

273

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

Plasma noradrenaline increases with age

17 October 2022

274

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

The sympathetic-nervous-system defect in primary orthostatic hypotension

17 October 2022

275

1 reference

https://api.crossref.org/works/10.1016/S0002-7138(09)61596-X

17 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18499

17 October 2022

1 reference